No Data
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
HPGC Renmintongtai Pharmaceutical Corporation (600829.SH) has appointed Gu Congfeng as the general manager.
HPGC Renmintongtai Pharmaceutical Corporation (600829.SH) announced that the company's Board of Directors recently received a submission from General Manager Mr. Zhu Weidong...
HPGC Renmintongtai Pharmaceutical Corporation's (SHSE:600829) 26% Dip In Price Shows Sentiment Is Matching Earnings
HPGC Renmintongtai Pharmaceutical Corporation (600829.SH): Currently operating five Shiyitang Chinese medicine clinics.
On January 7, Gelonghui reported that HPGC Renmintongtai Pharmaceutical Corporation (600829.SH) stated on the investor interaction platform that the company currently operates five Shiyitang Traditional Chinese Medicine stores. The company closely follows national policy guidance, adheres to integrity and innovation, and formulates a Global Strategy based on its own development situation.
Three consecutive boards HPGC Renmintongtai Pharmaceutical Corporation (600829.SH): Main Business has not undergone significant changes.
HPGC Renmintongtai Pharmaceutical Corporation (600829.SH) issued a risk warning announcement, the company is a pharmaceutical distribution enterprise, mainly engaged in the operation of pharmaceutical wholesale...
Are Robust Financials Driving The Recent Rally In HPGC Renmintongtai Pharmaceutical Corporation's (SHSE:600829) Stock?
HPGC Renmintongtai Pharmaceutical Corporation (SHSE:600829) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
